Reaction
Transplantation Complication reporting signals
As of the last recalculation, Transplantation Complication appears in 411 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 203.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Blinatumomab | 38 | 203.1 | 203.9 |
| Busulfan | 21 | 71.2 | 71.3 |
| Anti-Thymocyte Globulin (Rabbit) | 7 | 44.7 | 44.7 |
| Mycophenolic Acid | 26 | 43.8 | 43.9 |
| Mycophenilic Acid | 17 | 43.3 | 43.3 |
| Thiotepa | 8 | 43.2 | 43.3 |
| Melphalan | 18 | 41.9 | 41.9 |
| Basiliximab | 9 | 39.6 | 39.6 |
| Posaconazole | 12 | 38.5 | 38.5 |
| Melphalan Hydrochloride | 18 | 38.0 | 38.0 |
| Fludarabine Phosphate | 23 | 31.3 | 31.3 |
| Azacitidine For | 9 | 25.6 | 25.6 |
| Eculizumab | 21 | 20.6 | 20.6 |
| Azacitidine | 10 | 17.5 | 17.5 |